Novavax Inc (NVAX)

[TRUISM]

Novavax Inc. (NVAX) is Trading Lower On Unusual Volume For April 17
By Equities Staff / April 17, 2015 5:32PM
Click For Link



Novavax Inc. (NVAX) experienced unusually high volume on Apr. 17, as the stock lost 1.94% to a closing price of $8.07. The stock saw 7.13 million shares trade hands over the course of the day on 19,588 trades.

Given that the stock’s average daily volume over the last month has been 4.64 million shares a day, this represents a pretty substantial spike over the norm.

Novavax Inc. has a P/B ratio of 8.41. The stock has traded between $9.95 and $3.70 over the last 52-weeks, its 50-day SMA is now $8.70, and its 200-day SMA $6.04.

Novavax Inc is a clinical-stage vaccine company engaged in the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants.
Headquartered in Garthersburg, MD, Novavax Inc. has 308 employees and is currently under the leadership of CEO Stanley C. Erck.







TRUTH